Target Healthcare REIT (LON:THRL) Sets New 1-Year High – Still a Buy?

Target Healthcare REIT (LON:THRLGet Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 117 and last traded at GBX 116.40, with a volume of 2054494 shares traded. The stock had previously closed at GBX 116.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price target on shares of Target Healthcare REIT in a research note on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of GBX 101.

View Our Latest Stock Analysis on THRL

Target Healthcare REIT Trading Up 0.2%

The firm’s 50-day moving average price is GBX 108.85 and its two-hundred day moving average price is GBX 105.66. The stock has a market cap of £720.72 million, a PE ratio of 9.24, a PEG ratio of 1.48 and a beta of 0.70.

Target Healthcare REIT Company Profile

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

See Also

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.